Schistosome infection-derived Hepatic Stellate Cells are cellular source of prostaglandin D₂: role in TGF-β-stimulated VEGF production

Prostaglandins Leukot Essent Fatty Acids. 2015 Apr:95:57-62. doi: 10.1016/j.plefa.2015.01.004. Epub 2015 Feb 3.

Abstract

Hepatic Stellate Cells (HSCs) play a crucial role in pathogenesis of liver inflammation and fibrosis. During chronic liver injury, HSCs lose vitamin A and transform into myofibroblastic cells. In schistosomal granulomas, these activated HSCs are called GR-HSCs. Schistosomal-triggered hepatic fibrogenesis has TGF-β as the most potent fibrogenic stimulus, that also controls gene expression of the angiogenic molecule VEGF in HSCs. COX-dependent production of prostaglandins (PGs) also play role in angiogenic processes. Besides angiogenic roles, prostanoids control immunomodulation of Schistosoma mansoni infection. Specifically, schistosoma-derived PGD2 has emerged as a key parasite regulator of immune defense evasion, while no role is still established to host PGD2. Therefore, the aim of this work is to investigate the ability of GR-HSCs to synthesize COX-derived PGD2 and a potential role of this prostanoid in VEGF production by GR-HSCs in vitro. Here, we confirmed that GR-HSCs express COX-2, which displayed perinuclear localization. While unstimulated GR-HSCs produce basal levels of PGD2, TGF-β stimulation besides increasing COX2- mRNA levels, enhanced synthesis/secretion of PGD2 in GR-HSCs supernatant. Moreover, GR-HSCs-derived PGD2 mediate VEGF production by TGF-β-stimulated GR-HSCs, since the pre-treatment with HQL-79, an inhibitor of hematopoietic PGD synthase inhibited both PGD2 synthesis and VEGF secretion by TGF-β-stimulated GR-HSCs. All together, our findings show an autocrine/paracrine activity of GR-HSCs-derived PGD2 on TGF-β-induced VEGF production by GR-HSCs, unveiling a role for PGD2 as important regulator of HSCs activation in hepatic granulomas from schistosome infected mice.

Keywords: Eosinophil; Hepatic Stellate Cells; Prostaglandin D(2); S. mansoni; VEGF.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Communication / drug effects
  • Cells, Cultured
  • Cyclooxygenase 2 / genetics
  • Cyclooxygenase 2 / metabolism*
  • Granuloma / enzymology
  • Granuloma / metabolism*
  • Granuloma / parasitology
  • Hepatic Stellate Cells / enzymology
  • Hepatic Stellate Cells / metabolism
  • Hepatic Stellate Cells / parasitology*
  • In Vitro Techniques
  • Liver / metabolism
  • Liver / parasitology
  • Liver / pathology
  • Male
  • Mice
  • Piperidines / pharmacology
  • Prostaglandin D2 / metabolism*
  • Schistosomiasis mansoni / enzymology
  • Schistosomiasis mansoni / metabolism
  • Schistosomiasis mansoni / pathology*
  • Transforming Growth Factor beta / metabolism
  • Transforming Growth Factor beta / pharmacology*
  • Vascular Endothelial Growth Factor A / metabolism

Substances

  • 4-benzhydryloxy-1-(3-(1H-tetrazol-5-yl-)-propyl)piperidine
  • Piperidines
  • Transforming Growth Factor beta
  • Vascular Endothelial Growth Factor A
  • vascular endothelial growth factor A, mouse
  • Ptgs2 protein, mouse
  • Cyclooxygenase 2
  • Prostaglandin D2